The glucose monitoring global market is expanding at a steady rate, as estimated by IQ4I Research, the glucose monitoring global market is expected to grow at low single digit CAGR to reach $11,248.5 million by 2023.
The Invasive glucose monitoring products segment accounted the largest share.
The blood segment accounted the largest share other source based glucose monitoring segment is fastest growing segment Based on the end-user, the glucose monitoring global market is segmented into hospitals, private clinics, home care and ambulatory settings.
The glucose monitoring global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world.
The glucose monitoring market is consolidated because the majority of the glucose monitoring market is dominated by players such as Roche, Johnson & Johnson, Abbott, Medtronic, Ascensia, Dexcom, Arkray and BioRad control major share of the market as these companies have a strong distribution networks and have multiple channels to reach the patients, whereas, in CGM market competition is very limited due to technologies being protected by strong IP portfolio.